Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer

NCT00531687 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Testicular Cancer

Interventions

DRUG: Paclitaxel
DRUG: Cisplatin
DRUG: Gemcitabine

Sponsor

Rigshospitalet, Denmark